AAAAAA

   
Results: 1-18 |
Results: 18
ELEVATED PLASMA-FIBRINOGEN - CAUSE OR CONSEQUENCE OF CARDIOVASCULAR-DISEASE
Authors: VANDERBOM JG DEMAAT MPM BOTS ML HAVERKATE F DEJONG PTVM HOFMAN A KLUFT C GROBBEE DE
Citation: Jg. Vanderbom et al., ELEVATED PLASMA-FIBRINOGEN - CAUSE OR CONSEQUENCE OF CARDIOVASCULAR-DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 18(4), 1998, pp. 621-625
ACTIVATION PRODUCTS OF THE HEMOSTATIC SYSTEM IN CORONARY, CEREBROVASCULAR, AND PERIPHERAL ARTERIAL-DISEASE
Authors: VANDERBOM JG BOTS ML HAVERKATE F MEIJER P KLUFT C GROBBEE DE
Citation: Jg. Vanderbom et al., ACTIVATION PRODUCTS OF THE HEMOSTATIC SYSTEM IN CORONARY, CEREBROVASCULAR, AND PERIPHERAL ARTERIAL-DISEASE, Thrombosis and haemostasis, 1997, pp. 537-537
THE RISK OF SMOKING IS MODIFIED BY THE 4G ALLELE OF THE PAI-1 GENE
Authors: VANDERBOM JG BOTS ML SLAGBOOM PE HAVERKATE F MEIJER P KLUFT C GROBBEE DE
Citation: Jg. Vanderbom et al., THE RISK OF SMOKING IS MODIFIED BY THE 4G ALLELE OF THE PAI-1 GENE, Thrombosis and haemostasis, 1997, pp. 2366-2366
SEASONAL-VARIATION IN FIBRINOGEN IN THE ROTTERDAM STUDY
Authors: VANDERBOM JG DEMAAT MPM BOTS ML HOFMAN A KLUFT C GROBBEE DE
Citation: Jg. Vanderbom et al., SEASONAL-VARIATION IN FIBRINOGEN IN THE ROTTERDAM STUDY, Thrombosis and haemostasis, 78(3), 1997, pp. 1059-1062
THE EFFECT OF HORMONE REPLACEMENT THERAPY ON HEMOSTATIC PARAMETERS INPERIMENOPAUSAL AND POSTMENOPAUSAL WOMEN
Authors: BAK AAA WITTEMAN JCM PLANELLAS J VANDERBOM JG BENNINK HJTC GROBBEE DE
Citation: Aaa. Bak et al., THE EFFECT OF HORMONE REPLACEMENT THERAPY ON HEMOSTATIC PARAMETERS INPERIMENOPAUSAL AND POSTMENOPAUSAL WOMEN, Atherosclerosis, 134(1-2), 1997, pp. 178-178
TISSUE-PLASMINOGEN ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION - THE ROTTERDAM STUDY
Authors: VANDERBOM JG DEKNIJFF P HAVERKATE F BOTS ML MEIJER P DEJONG PTVM HOFMAN A KLUFT C GROBBEE DE
Citation: Jg. Vanderbom et al., TISSUE-PLASMINOGEN ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION - THE ROTTERDAM STUDY, Circulation, 95(12), 1997, pp. 2623-2627
RESPONSE TO ACTIVATED PROTEIN-C AND CEREBROVASCULAR-DISEASE - RESPONSE
Authors: VANDERBOM JG BOTS ML KLUFT C
Citation: Jg. Vanderbom et al., RESPONSE TO ACTIVATED PROTEIN-C AND CEREBROVASCULAR-DISEASE - RESPONSE, Annals of internal medicine, 126(10), 1997, pp. 833-833
ANTITHROMBIN AND ATHEROSCLEROSIS IN THE ROTTERDAM STUDY
Authors: VANDERBOM JG BOTS ML VANVLIET HHDM POLS HAP HOFMAN A GROBBEE DE
Citation: Jg. Vanderbom et al., ANTITHROMBIN AND ATHEROSCLEROSIS IN THE ROTTERDAM STUDY, Arteriosclerosis, thrombosis, and vascular biology, 16(7), 1996, pp. 864-867
FIBRINOLYTIC CAPACITY AND RISK OF MYOCARDIAL-INFARCTION
Authors: VANDERBOM JG BOTS ML HAVERKATE F GROBBEE DE KLUFT C
Citation: Jg. Vanderbom et al., FIBRINOLYTIC CAPACITY AND RISK OF MYOCARDIAL-INFARCTION, Fibrinolysis, 10, 1996, pp. 9-12
ACTIVATED PROTEIN-C RESPONSE AND CARDIOVASCULAR RISK-FACTORS IN THE ELDERLY - THE ROTTERDAM STUDY
Authors: BOTS ML VANDERBOM JG HAVERKATE F MEIJER P HOFMAN A GROBBEE DE KLUFT C
Citation: Ml. Bots et al., ACTIVATED PROTEIN-C RESPONSE AND CARDIOVASCULAR RISK-FACTORS IN THE ELDERLY - THE ROTTERDAM STUDY, Fibrinolysis, 10, 1996, pp. 161-164
PLASMA-FIBRINOGEN IN NIDDM - THE ROTTERDAM STUDY
Authors: MISSOV RM STOLK RP VANDERBOM JG HOFMAN A BOTS ML POLS HAP GROBBEE DE
Citation: Rm. Missov et al., PLASMA-FIBRINOGEN IN NIDDM - THE ROTTERDAM STUDY, Diabetes care, 19(2), 1996, pp. 157-159
ACTIVATED PROTEIN-C AND RISK OF STROKE AND TRANSIENT ISCHEMIC ATTACK
Authors: VANDERBOM JG BOTS ML GROBBEE DE SLAGBOOM PE HAVERKATE F MELLER P KLUFT C
Citation: Jg. Vanderbom et al., ACTIVATED PROTEIN-C AND RISK OF STROKE AND TRANSIENT ISCHEMIC ATTACK, Circulation, 93(3), 1996, pp. 10-10
FIBRINOGEN IS A PREDICTOR OF STROKE - THE ROTTERDAM STUDY
Authors: BOTS ML VANDERBOM JG HOES AW KOUDSTAAL PJ HOFMAN A GROBBEE DE
Citation: Ml. Bots et al., FIBRINOGEN IS A PREDICTOR OF STROKE - THE ROTTERDAM STUDY, Circulation, 93(3), 1996, pp. 43-43
REDUCED RESPONSE TO ACTIVATED PROTEIN-C IS ASSOCIATED WITH INCREASED RISK FOR CEREBROVASCULAR-DISEASE
Authors: VANDERBOM JG BOTS ML HAVERKATE F SLAGBOOM PE MEIJER P DEJONG PTVM HOFMAN A GROBBEE DE KLUFT C
Citation: Jg. Vanderbom et al., REDUCED RESPONSE TO ACTIVATED PROTEIN-C IS ASSOCIATED WITH INCREASED RISK FOR CEREBROVASCULAR-DISEASE, Annals of internal medicine, 125(4), 1996, pp. 265
FACTOR-V MUTATION, APC RESISTANCE AND MYOCARDIAL-INFARCTION IN THE ROTTERDAM STUDY
Authors: VANDERBOM JG KLUFT C BOTS ML HAVERKATE F SLAGBOOM E MEIJER P GROBBCE DE
Citation: Jg. Vanderbom et al., FACTOR-V MUTATION, APC RESISTANCE AND MYOCARDIAL-INFARCTION IN THE ROTTERDAM STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 1373-1373
POLYMORPHISM OF THE BLOOD-CLOT LYSIS ENZYME TISSUE-TYPE PLASMINOGEN-ACTIVATOR IS ASSOCIATED WITH MYOCARDIAL-INFARCTION
Authors: VANDERBOM JG DEKNIJFF P BOTS ML HAYERKATE F HOLMAN A KLUFT C GROBBEE DE
Citation: Jg. Vanderbom et al., POLYMORPHISM OF THE BLOOD-CLOT LYSIS ENZYME TISSUE-TYPE PLASMINOGEN-ACTIVATOR IS ASSOCIATED WITH MYOCARDIAL-INFARCTION, Circulation, 92(8), 1995, pp. 140-140
FACTOR-VII COAGULANT ACTIVITY IS RELATED TO BLOOD-LIPIDS IN THE ELDERLY - THE ROTTERDAM STUDY
Authors: VANDERBOM JG BOTS ML VANVLIET HHDM HOFMAN A GROBBEE DE
Citation: Jg. Vanderbom et al., FACTOR-VII COAGULANT ACTIVITY IS RELATED TO BLOOD-LIPIDS IN THE ELDERLY - THE ROTTERDAM STUDY, Fibrinolysis, 8, 1994, pp. 132-134
MEASUREMENT OF BETA-THROMBOGLOBULIN IN THE ELDERLY - FINDINGS FROM THE ROTTERDAM STUDY
Authors: VANDERBOM JG BOTS ML DEBRUIJN AM HOFMAN A GROBBEE DE
Citation: Jg. Vanderbom et al., MEASUREMENT OF BETA-THROMBOGLOBULIN IN THE ELDERLY - FINDINGS FROM THE ROTTERDAM STUDY, Fibrinolysis, 8, 1994, pp. 157-159
Risultati: 1-18 |